BUFFALO GROVE, Ill., Jan. 3 /PRNewswire/ -- Alma Lasers Ltd. ("Alma Lasers") announced today that it has filed a registration statement with the U.S. Securities and Exchange Commission relating to its proposed underwritten initial public offering of its ordinary shares.
The initial public offering is expected to consist of newly issued shares being offered by Alma Lasers and secondary shares offered by certain stockholders. In addition, Alma Lasers expects to grant the underwriters an option to purchase additional ordinary shares to cover over-allotments, if any.
Citigroup Global Markets Inc. and UBS Investment Bank will serve as joint bookrunning managers, William Blair & Company, L.L.C. will serve as lead manager, and Jefferies & Company, Inc. will serve as co-manager for the proposed offering.
A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offer or sale will be made only by means of a written prospectus forming part of the effective registration statement.
Once available, a preliminary prospectus relating to these securities may be obtained by contacting Citigroup Global Markets Inc., Brooklyn Army Terminal, 140 58th Street, Brooklyn, New York 11220, Attn: Prospectus Department or UBS Investment Bank, Prospectus Department, 299 Park Avenue, New York, New York 10171.
About Alma Lasers
Alma Lasers is a global medical technology company that designs, develops, manufactures and markets laser, intense pulsed light and radiofrequency based aesthetic treatment devices that can be used to treat a broad range of skin types and indications. Alma Lasers believes that its products have typically been at the forefront of technological development in the energy-based aesthetic treatment system market. Since commercializing its first aesthetic treatment system in 2002, Alma Lasers has introduced eight systems that work in combination with approximately 19 handpieces. Alma Lasers' mission is to leverage its technical expertise and in-depth understanding of practitioners' needs in order to provide modular, cost-effective and high performance designs that enable medical practitioners to confidently offer safe, effective and profitable aesthetic treatments to their patients.
CONTACT: William Bruckner, Vice President, Global Marketing,
+1-224-377-2010, firstname.lastname@example.org, or Shai Halivni, Vice President,
General Counsel, +1-224-377-2008, email@example.com, both of Alma Lasers
Web site: http://www.almalasers.com/